RSS Feed

How Pfizer Hid Nearly 80% of COVID Vaccine Trial Deaths From Regulators

November 6th, 2023

Awake Goy

10/27/23

According to an analysis, published this month in the International Journal of Vaccine Theory, Practice, and Research, of Pfizer-BioNTech COVID-19 vaccine clinical trial data, the vaccine makers hid fatality data from regulators in order to qualify for Emergency Use Authorization.

By

Angelo DePalma, Ph.D.

Miss a day, miss a lot. Subscribe to The Defender’s Top News of the Day. It’s free.

Pfizer-BioNTech delayed reporting vaccine-associated deaths among BNT162b2 clinical trial participants until after the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the product.

The vaccine makers also failed to account for a large number of subjects who dropped out of the trial.

Together, these strategies kept regulators and the public ignorant of a 3.7-fold increase in cardiac deaths among subjects who received the vaccine, according to analysis in the International Journal of Vaccine Theory, Practice, and Research.

The authors of the paper described it as a “forensic analysis,” defined by the U.S. National Institute for Standards and Technology as “the use of scientific methods or expertise to investigate crimes or examine evidence that might be presented in a court of law.”

What the analysis shows

Corinne Michels, Ph.D., retired distinguished professor of biology at Queens College, New York, led the DailyClout Pfizer/BioNTech Documents Investigations Team on what the authors claim was the first independent examination of original data from the Pfizer-BioNTech COVID-19 mRNA vaccine (BNT162b2) clinical trial.

Investigators looked at each of the 38 deaths occurring between July 27, 2020, the start of phase 2/3 of the Pfizer-BioNTech vaccine trial, and March 13, 2021, the end date culminating in Pfizer-BioNTech’s 6-month interim report.

This trial phase involved 44,060 subjects. Half received a dose of BNT162b2, half got a placebo consisting of an inactive sterile salt solution.

The trial was unusual because at week 20 after the FDA issued the EUA for the vaccine, trial subjects in the placebo group were allowed to switch to the vaccinated group and receive their first BNT162b2 shot.

RFK Jr. and Brian Hooker’s New Book: “Vax-Unvax”

ORDER NOW

Switching from the placebo to the vaccinated group — or “unblinding” — normally occurs when the benefit of the drug is so great that not treating subjects becomes unethical. For example, investigators might consider unblinding a cancer trial if at some point all untreated patients deteriorated or died but all treated patients improved.

Unblinding conditions may be specified in the study design, but they usually involve input or review from medical ethicists.

Of 20,794 unblinded placebo subjects in the Pfizer trial, 19,685 received at least one dose of BNT162b2.

Normally the decision to unblind a vaccine trial would be based on the product’s safety and effectiveness in reaching certain endpoints or objectives. Endpoints for a drug to prevent viral infections might be a positive test or self-reported COVID-19 illness (the “case” numbers that drove much of COVID-19 policy), illness requiring hospitalization or death.

But, perhaps unexpectedly, after 33 weeks the data revealed no significant difference between deaths in the vaccinated and placebo groups for the initial 20-week placebo-controlled portion of the trial.

After week 20, after most former placebo subjects had received the vaccine, deaths among those in the vaccine group continued unabated.

The authors revealed “inconsistencies” between data presented in Pfizer-BioNTech’s 6-month interim report and subsequent publications by Pfizer-BioNTech trial site administrators:

“Most importantly, we found evidence of an over 3.7-fold increase in the number of deaths due to cardiac events in the BNT162b2 vaccinated individuals compared to those who received only the placebo.”

This means that 79% of relevant deaths were not recorded in time to be included in Pfizer’s regulatory paperwork.

By not including relevant subject deaths in the case report, Pfizer obscured cardiac adverse event signals, allowing the EUA to proceed unchallenged.

How did Pfizer get around legal, ethical obligations?

The Pfizer-BioNTech data, obtained through a Freedom of Information Act lawsuit, uncovered four additional deaths in the vaccine group and one more in the placebo group — but Pfizer failed to include these data in their FDA submission despite an explicit study design requirement to do so.

These data, and how they differ from what Pfizer-BioNTech reported in their applications, are summarized in Table 3 of Michels’ study.

One case involved a 63-year-old woman who died 41 days after receiving the shot, but whose death only entered the data pool 37 days later. Another was a 58-year-old woman whose death 72 days after vaccination went unreported for 26 days.

Had Pfizer-BioNTech met their legal and ethical obligation to report all serious adverse events their data would have shown equal deaths in placebo and vaccine groups — which would have shown no clear benefit for the vaccine.

How were they able to skirt those obligations?

For one, they were able to hide behind the the 2005 Public Readiness and Emergency Preparedness (PREP) Act, which provided an almost impenetrable liability shield for vaccine manufacturers for “medical countermeasures” in response to any “public health emergency.”

Second, because COVID-19 was viewed as a national health emergency, regulators abandoned the established, patient-centered, safety-based approval process requiring years of preclinical animal testing — and Pfizer-BioNTech unsurprisingly went along.

“The Wuhan Cover-Up” by Robert F. Kennedy Jr.

ORDER NOW

Timing of death reports raises questions

Michels also raised issues regarding total death reports and their timing.

Since the death total from both study groups, 38, appeared “surprisingly low” to study authors — particularly during a pandemic — they undertook their own analysis based on population mortality expectations at the time.

Assuming that age-adjusted death rates for the study subjects were similar to those of the general population, they estimated that 222 subjects should have died from July 27, 2020, to March 13, 2021. The reported number, 38, is just 18% of the expected number.

Michels explained this by the large number, 4.2% of “discontinued subjects.” The most concerning of these were subjects “lost to follow-up,” which means missing scheduled visits or other required activities.

Pfizer-BioNTech tried to reach these subjects via phone, certified mail or through their emergency contact but despite their efforts could not account for 395 subjects who had dropped out.

The authors wrote:

“These are not insignificant numbers and could easily account for the low number of deaths reported in this safety period of the trial. Given the importance of knowing the status of each trial subject, there should have been greater effort to locate these individuals.

“Additionally, Pfizer/BioNTech was responsible for oversight of the trial sites. Sites with excessive numbers of lost to follow-up should have been evaluated for performance.”

Michels was also concerned over how certain trial centers had many dropped-out subjects while others had none or just a few.

Ninety-six of 153 trial sites (63%) reported 0 or 1 subjects lost to follow-up and 34 (22%) reported 2-5 dropouts. But four sites reported more than 20 subjects lost to follow-up, amounting to about 5% of all trial subjects.

Since the vaccine makers were responsible for trial site oversight, the authors wrote, “Sites with excessive numbers of lost to follow-up should have been evaluated for performance.”

Finally, based on the data, it appears Pfizer-BioNTech was in no hurry to enter death reports before the EUA submission deadline, particularly for the BNT162b2 group.

Of the 38 reported deaths only one case was added on the day the subject died. Delays of 20+ and 30+ days were common.

One death took 72 days to find its way into the database, and all were entered as occurring on the reporting day, not on the actual date of death.

Of the eight subjects in the vaccine group that should have been reported by Dec. 10, 2020, the EUA application cutoff, the average reporting delay was 17.5 days for subjects in the vaccine group, but just 5.9 days for deaths among subjects in the placebo group.

How Pfizer Hid Nearly 80% of COVID Vaccine Trial Deaths From Regulators

_______________________________

The Time for Silence is Over

https://www.uncoverdc.com/2022/10/21/a-message-to-humanity-the-time-for-silence-is-over/

If you are a doctor or medical professional and you are reading this and aware of what is happening, the time for you to stay silent on account of self-preservation is over. The weight of what you know vs. a license, a job, etc., is too great. “Just following orders” or fear of scrutiny won’t cut it anymore. Several have come before you to lay the groundwork so you, too, can be brave.

If you are the every-man, there are still people you haven’t spoken to. Call them today. Don’t wait. Prepare your information, and get it ready for an email or text. Sit with them and discuss it. Have them over. Watch an interview or seminar. Make them stay out of respect for you because you are respecting them; you are trying to save their life.

If you are the every-man with a bit more nerve, go stand outside of your nearest school with a packet of information to hand out to parents on the car line. Do it until they threaten to arrest you, and get arrested if you must. It is that serious. It must be done. Go to a mall and flier the windshields of every car in the parking lot. Create a landing page or send people to a reputable site with the needed information. Get your boots on the ground. Do it today. Do not wait. Your fellow human needs you right now.

We are in the midst of one of the greatest psychological operations in human history.

https://www.reignitefreedom.com/

The third step is to unsubscribe from all mainstream media outlets. Delete the apps from your phone, laptop, and tablet and unfollow all of their social media and YouTube channels. Try to avoid mainstream media for at least one week, even if the headline is intriguing.

In the same time why not removing all the big tech tracking/spying/social credit system around you: (Youtube, Facebook, Instagram, Twitter, Tik Tok, Google, Apple, Microsoft, Whatsapp, Zoom, Linkedln, Snapchat, Tumblr, Pinterest, Reddit, Myspace, etc.)

The fourth step of the global walkout is to move as many accounts as you can to a union or local bank.

https://community.covidvaccineinjuries.com/compilation-peer-reviewed-medical-papers-of-covid-vaccine-injuries/

If you like our work please consider to donate :

Donate Crypto

_______________________________

If you are looking for solutions (lawyer, form, gathering, action, antidote, treatments, maybe this could help you:
HERE

If you want to fight back better:
https://childrenshealthdefense.org/child-health-topics/health-freedom/defender-days-sticker-gallery/

Find the others: www.freedomcells.org

www.thegreaterreset.org

Spike Protein Protocol

McCullough MD (aug 2023):

He recommended three supplements to mitigate harm and degrade spike proteins:

1. Nattokinase – 2000 units twice a day. Breaks down spike protein.
2. Bromelain – 500 milligrams once a day. Also breaks down spike protein.
3. Curcumin – 500 milligrams twice a day. Reduces inflammation and spike protein damage.

Urotherapy https://urotherapyresearch.com/ https://rumble.com/v2wsgmv-dir-ep8-heal-your-mitochondria-with-urotherapy-and-cutting-edge-regenerativ.html
Glutathione (most important for body detoxification) or better
NAC = N-Acetyl-Cysteine 600-750mg (causes the body to produce glutathione itself)
Zinc
Astaxantin 5mg (also improves vision)
Quercetin
vitamin D3
Milk thistle (also liver and stomach protection)
Melatonin 1mg to 10mg (against 5G)
Alternatively CDS/CDL and zeolite